β-Blocker Use in Pregnancy and the Risk for Congenital Malformations: An International Cohort Study.

Conclusion: The results suggest that maternal use of β-blockers in the first trimester is not associated with a large increase in the risk for overall malformations or cardiac malformations, independent of measured confounders.
Primary Funding Source: The Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Söderström König Foundation.
PMID: 30326014 [PubMed - as supplied by publisher]

Source: Annals of Internal Medicine - October 16, 2018 Category: Internal Medicine Authors: Bateman BT, Heide-Jørgensen U, Einarsdóttir K, Engeland A, Furu K, Gissler M, Hernandez-Diaz S, Kieler H, Lahesmaa-Korpinen AM, Mogun H, Nørgaard M, Reutfors J, Selmer R, Huybrechts KF, Zoega H Tags: Ann Intern Med Source Type: research